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HIV-1 Nef is a pleiotropic modulator of various cellular
signaling proteins and cell surface receptors. It conditions
cells for viral replication by aiding in immune evasion and
priming T-cell activation, and also enhances HIV-1 infectivity by a poorly defined mechanism. Most of described
effects of Nef, such as downregulation of CD4 and MHC I,
involve Nef binding to the target protein and directing it
to a degradation pathway. We have demonstrated
previously that Nef causes degradation and functional
impairment of ABCA1, the major cellular cholesterol
transporter, an effect that likely contributes to low HDL
levels and high risk of atherosclerosis in HIV-infected
patients. Surprisingly, direct interaction between Nef and
ABCA1 was not required for ABCA1 inactivation. Here
we investigated the mechanism of this Nef activity using
proteomics, co-immunoprecipitation, mutagenesis, confocal microscopy, and subcellular fractionation approaches.
These studies identified calnexin, an endoplasmic reticulum (ER) resident lectin-like chaperone, as an essential
partner of ABCA1 and a target of Nef, and characterized
Nef- calnexin interaction and its effects on interactions
between calnexin and its other partners, such as gp160.
We demonstrated that Nef binds to calnexin and increases
affinity and enhances interaction of calnexin with HIV-1
gp160, but disrupts calnexin interaction with ABCA1.
Interaction with calnexin is essential for functionality
of both these proteins, as knock-down of calnexin led
to reduced infectivity of HIV-1, as well as to defective
cholesterol efflux. However, gp160 and ABCA1 interacted
with calnexin differently: while gp160 binding to calnexin
was dependent on glycosylation, glycosylation was of little
importance for interaction between ABCA1 and calnexin.
Thus, Nef binding appears to induce a conformational
change in calnexin that stimulates glycosylation-dependent
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interaction of calnexin with gp160 at the expense of
glycosylation-independent interaction with ABCA1. This
study identifies a novel mechanism for Nef-dependent
inactivation of ABCA1, provides an additional explanation
for the effect of Nef on HIV-1 infectivity, and suggests a
number of other potential targets of this new Nef activity.
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